Sort
78,016 grants matching “breast cancer”
HOWARD UNIVERSITY CANCER CENTER PLANNING GRANT
$472,933Howard University · P20 · FY2002 · CA
Coordination of stress-adaptive cell states by CRIPTO in breast cancer heterogeneity and progression
$472,921Benjamin T Spike · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
A Quality Control Program for Quantitative MRI Data Acquisition and Analysis in Multi-site Clinical Trials
$472,890Todor Karaulanov · Calibermri, Inc. · R44 · FY2021 · CA
IMMUNOTHERAPY
$472,747Duke University · P01 · FY2000 · CA
Dose Reduction in Pediatric Molecular Imaging
$472,741George Sgouros · Johns Hopkins University · R01 · FY2014 · EB
FACILITATING POSITIVE ADAPTATION TO BREAST CANCER
$472,732University Of Miami Coral Gables · R01 · FY2000 · CA
Sex steroid signaling and adaptive growth of the intestine
$472,704Bruce A Edgar · University Of Utah · R01 · FY2023 · DK
Sex steroid signaling and adaptive growth of the intestine
$472,704Bruce A Edgar · University Of Utah · R01 · FY2022 · DK
Defining role of FANCA in genome instability
$472,695Yanbin Zhang · University Of Miami School Of Medicine · R01 · FY2022 · HL
Defining role of FANCA in genome instability
$472,695Yanbin Zhang · University Of Miami School Of Medicine · R01 · FY2023 · HL
Mindfulness Based Stress Reduction for Psycho-Immune Dysregulation in Cancer
$472,673Herbert L Mathews · Loyola University Chicago · R01 · FY2010 · CA
MULTIDOMAIN ASSEMBLY OF NUCLEAR ESTROGEN RECEPTORS: STRUCTURAL INSIGHTS INTO ER-POSITIVE BREAST CANCER THERAPEUTICS
$472,668University Of Chicago · · FY2011 · Department of the Army
Combination Therapy for Pancreatic Cancer
$472,623Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Combination Therapy for Pancreatic Cancer
$472,623Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
RADIOPHARMACY AND ASSAYS
$472,615David Morris Colcher · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA
C35: A Target for Bladder and Breast Cancer Therapy
$472,605Vaccinex, Inc. · R44 · FY2001 · CA
Regulation of APOBEC3 cytidine deaminase-induced mutation during cancerdevelopment
$472,605Steven A Roberts · University Of Vermont & St Agric College · R01 · FY2025 · CA
EPIGENETIC SUBTYPES OF TRIPLE NEGATIVE BREAST CANCER
$472,600Dana-Farber Cancer Institute, Inc. · · FY2014 · Department of the Army
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$472,585Andrew E Aplin · Thomas Jefferson University · R01 · FY2022 · CA
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$472,585Andrew E Aplin · Thomas Jefferson University · R01 · FY2023 · CA
MEASUREMENT ERRORS IN CANCER EPIDEMIOLOGY
$472,574Brigham And Women'S Hospital · R01 · FY2001 · CA
ILLINOIS ONCOLOGY RESEARCH ASSOCIATION CCOP
$472,573Methodist Medical Center Of Illinois · U10 · FY2001 · CA
Nanotechnology for targeted therapy and fundamental understanding of therapeutic resistance in triple negative breast cancer
$472,539Xiaoming He · Univ Of Maryland, College Park · R01 · FY2020 · CA
Multiplexed functional analysis of BRCA1and BARD1 missense variants in DNA repair
$472,538Jeffrey D Parvin · Ohio State University · R01 · FY2019 · CA
Obesity, Metabolism and Breast Cancer Metastasis
$472,530Dorothy Teegarden · Purdue University · R01 · FY2019 · CA